AstraZeneca corrects financial-info accident; Strides eyes sale of Aussie generics unit;

@FiercePharma: Apparently BMS' strategy guy went out with a bang: $2.5B deal for hep C developer Inhibitex. News | Follow @FiercePharma

> AstraZeneca ($AZN) scrambled to reaffirm its Dec. 20 guidance figures after alternate numbers were mistakenly released to analysts. Report

> India's Strides Arcolab may sell off its Australian branded generics business, plus certain drug manufacturing units, to focus on specialty injectables. More

> Biogen Idec ($BIIB) says its 2012 goals include boosting Tysbri sales by better identifying patients at risk of side effects and expanding Fampyra's European footprint through additional launches. Release

> Indian officials will inspect 6 Chinese bulk-drug manufacturing facilities next month after complaints about manufacturing infractions. Story

> Sigma-Aldrich said it would buy bioharmaceutical testing services company BioReliance Holdings from the private equity firm Avistal Capital Partners for $350 million in cash. Item

> China's Fosun Pharmaceutical is eyeing an IPO in Hong Kong in March, aiming to raise $600 million to $800 million, Reuters says. News

> Indian analysts said an unattractive IPO market will prompt more private equity investment in domestic pharma this year. Story

Biotech News

@FierceBiotech: GSK, Theravance will file for approval of lung drug Relovair despite mixed batch of clinical data. Article | Follow @FierceBiotech

@JohnCFierce: Big biotech buyouts are fine, but I'd prefer a hot IPO market any day. And what are the chances of that this year? Article | Follow @JohnCFierce

@MarkHFierce: Two overexpressed genes + excess MeCP2 protein = anxious mice. Maybe someday this could help some anxious people. Story | Follow @MarkHFierce

@MaureenFierce: Greenpeace activist leading project to reduce vax spoilage in emerging markets using solar-powered coolers, fridges. Story | Follow @MaureenFierce

> Bristol bags hot hep C drug developer Inhibitex for $2.5B. News

> JPM kicks off with fevered focus on the next big biotech deal. More

Medical Device News

> Philips sues Zoll alleging infringement of patents covering defibrillators. Item

> Ventana inks separate companion Dx deals. More

> FDA: J&J, others must study safety of vaginal mesh. Story

> Cook to invest $21M in Ireland, eyes India for expansion. Article

Biotech IT News

> Knome taps Pfizer vet as new CEO. Article

> Accelrys CEO hints at more buyouts after VelQuest acquisition. News

> Bristol-Myers Squibb outsources network duties to British Telecom. Story

> Quintiles starts digital unit in online hunt for study patients. More

> New software aids RNA cocktail against cancer. Item

And Finally... The Obama administration filed its first set of briefs defending the 2010 healthcare reform law with the Supreme Court. Report